How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30

Cited by (551)

Items 401–500 of 551

  1. Relationship of rare disorder latent clusters to anxiety and depression symptoms.
    Kathleen R. Bogart, Sarah Siodmok Dermody · 2019 · Health Psychology
  2. Survey on symptoms in patients receiving chemotherapy in an Italian department of oncology: a comparison between period prevalences
    Francesca Crivelli, Elisa Perfetti, Barbara Sartorello, V. Cantele, Paola Ostano, Francesco Ilardi, Dino Stefano Di Massimo, Mario Alberto Clerico · 2020 · Supportive Care in Cancer
  3. Patient reported outcomes interfering with daily activities in prostate cancer patients receiving antineoplastic treatment
    Dag Rune Stormoen, Christina Bæksted, Gry Assam Taarnhøj, Christoffer Johansen, Helle Pappot · 2021 · Acta Oncologica
  4. Importance of patient-reported outcomes and health-related quality of life when considering prostate cancer treatment
    James Hok‐Leung Tsu · 2020 · Hong Kong Medical Journal
  5. Exploring patient reported quality of life in lung cancer patients: A qualitative study of patient‐reported outcome measures
    Elena Jensen‐Marini, Darshini Ayton, John Raymond Zalcberg, Rob G. Stirling · 2024 · Asia-Pacific Journal of Clinical Oncology
  6. Systematic development of a patient-reported ONCOlogical-ROUTinE-Screening (ONCO-ROUTES) procedure at the University Cancer Center Regensburg
    Julia Maurer, Anna Saibold, Katharina Gerl, Michael T Koller, Oliver Koelbl, Tobias Pukrop, Sandra Windschüttl, Sabine Einhell, Anne Herrmann-Johns, Georgios Raptis et al. · 2024 · Journal of Cancer Research and Clinical Oncology
  7. Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation
    Phoi Phoi Diep, Corina S. Rueegg, Marta Maria Burman, Lorentz Brinch, Kristine Bø, Kristian Fosså, Linn Landrø, Jon Håvard Loge, May Brit Lund, Richard John Massey et al. · 2022 · Journal of Adolescent and Young Adult Oncology
  8. Malnutrition in Head and Neck Cancer: A Patient-reported Outcome Study
    ANDREAS COFRÉ, STEFANIE WALTER, Jens Büntzel, Jutta Hübner · 2023 · Anticancer Research
  9. Patient-Reported Outcomes in Myelodysplastic Syndromes: the Move from Life Span to Health Span
    Shimoli Vipul Barot, Bhumika J. Patel, Aaron Thomas Gerds · 2020 · Current Hematologic Malignancy Reports
  10. „Patient-reported outcome measures“
    Christoph Kowalski, Jutta Hübner · 2020 · Forum
  11. Physician- and Patient-Reported Symptom Concordance and Association with Quality of Life in Hepatocellular Carcinoma
    Andrea Leith, Urpo Kiiskinen, Allicia C. Girvan, Min‐Hua Jen, Keerun Khela, Alex Rider, Lucy Massey, James Piercy · 2022 · Future Oncology
  12. Patient-reported outcomes for oral oncolytic therapy: A pilot study utilizing an electronic patient portal in a community cancer center
    Claire E. Saadeh, Maja Hill, Samuel Snowaert · 2023 · Journal of Oncology Pharmacy Practice
  13. Adverse event signal extraction from cancer patients’ narratives focusing on impact on their daily-life activities
    Satoshi Nishioka, Masaki Asano, Shuntaro Yada, Eiji Aramaki, Hiroshi Yajima, Yuki Yanagisawa, Kyoko Sayama, Hayato Kizaki, Satoko Hori · 2023 · Scientific Reports
  14. The perception gap of chemotherapy-induced adverse events between doctors and cancer patients: an observational study in China
    Juan Yu, Zhen Zhang, Huaqiang Zhou, Xia Liu, Yan Huang, Wenfeng Fang, Yunpeng Yang, Shaodong Hong, Ting Zhou, Yaxiong Zhang et al. · 2020 · Supportive Care in Cancer
  15. Electronic patient-reported outcome (e-PRO) monitoring for adverse event management during cabozantinib treatment in patients with advanced renal cell carcinoma: protocol for a three-arm, randomised, multicentre phase II trial (e-PRO vs paper-PRO or usual care)
    Takahiro Osawa, Yasuhisa Fujii, Go Kimura, Hiroshi Kitamura, Yoji Nagashima, Sakura Iizumi, Tsuyoshi Osaka, Ryoichi Tsubouchi, Nobuo Shinohara · 2023 · BMJ Open
  16. Cardiovascular Toxicity of Antitumor Drugs: Dimension of the Problem in Adult Settings
    Joseph R. Carver, Chaitali J. Desai · 2010 · Wiley eBooks
  17. Feasibility and usefulness of symptom monitoring with electronic patient-reported outcomes: an experience at single-center outpatient oncology clinic
    Saiko Kurosawa, Kumiko Koike, Tsunemi Arai, Sonomi Yoshida, Misato Ito, Yuki Kuriyama, Masayuki Kitahara, Takashi Rokuhara, Takuhiro Yamaguchi, Nobumichi Takeuchi · 2024 · Supportive Care in Cancer
  18. Patient-Reported Outcome Measures (PROMS) in Lymphoma
    Neha Akkad, Christopher R. Flowers · 2025 · Current Oncology
  19. Impact of Definitive Chemoradiation on Quality-of-Life Changes for Patients With Anal Cancer: Long-term Results of a Prospective Study
    Ali Hosni, Jolie Ringash, Kathy Han, Zhihui (Amy) Liu, James D. Brierley, Rebecca K.S. Wong, Laura A. Dawson, Bernard J. Cummings, Monika Karolina Krzyzanowska, Eric X. Chen et al. · 2022 · Diseases of the Colon & Rectum
  20. Oral oncolytic monitoring pilot with patient-reported outcomes and adherence assessments
    Jessie Signorelli, Christopher S. Bell, Stephanie Monaco · 2022 · Journal of Oncology Pharmacy Practice
  21. Patient‐reported outcomes in immunotherapy for head and neck cancer
    Kedar Kirtane, Aasha I. Hoogland, Xiaoyin Li, Yvelise Rodriguez, Kelsey L. Scheel, Brent J. Small, Laura B. Oswald, Jameel Muzaffar, Julie Ann Kish, Marcelo Raul Bonomi et al. · 2023 · Head & Neck
  22. Prevalence of Adverse Event Reporting in Adolescents and Young Adults Enrolled in Cancer Clinical Trials
    Cole Wayant, Kyle Fitzgerald, Christian E. Hemmerich, Yimin Geng, David R. Freyer, Michael E. Roth · 2023 · JCO Oncology Practice
  23. Benchmarks of success in radiotherapy vs systemic therapy: National Clinical Trials Network (NCTN) randomized controlled trials sponsored by the National Cancer Institute (NCI)
    Nina Niu Sanford, Qian Shi, David Hein, William Adrian Hall · 2024 · JNCI Journal of the National Cancer Institute
  24. Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy
    Joshua R. Niska, C.S. Thorpe, Michele Y. Halyard, Angelina D. Tan, Pamela J. Atherton, Amylou Constance Dueck, Samir H. Patel, Jeff A. Sloan · 2020 · Journal of Patient-Reported Outcomes
  25. Gynecologic Survivorship Tool: Development, Implementation, and Symptom Outcomes
    Jeanne Carter, Nadeem R. Abu-Rustum, Sally Saban, Ling Y. Chen, Andrew J. Vickers, Amy L. Tin, Gabriela Billanti, Nicole A. Connors, Vance Broach, Carol L. Brown et al. · 2022 · JCO Clinical Cancer Informatics
  26. Edmonton Symptom Assessment Scale may reduce medical visits in patients undergoing chemotherapy for breast cancer
    Valeria Sanna, Palma Fedele, Giulia Deiana, Maria Grazia Alicicco, Chiara Ninniri, Anna Natalizia Santoro, Antonio Pazzola, Alessandro Fancellu · 2022 · World Journal of Clinical Oncology
  27. Correlation of Clinician- and Patient-Reported Outcomes in the BC2001 Trial
    L. Philipps, Núria Porta, Nicholas David James, Robert Anthony Huddart, Shaista Hafeez, Emma Hall · 2023 · Clinical Oncology
  28. Integration of Daily Patient-Reported Outcome Measures in Pediatric Stem Cell Transplantation
    Benjamin Hetzer, Andreas Meryk, Gabriele Kropshofer, Christina Salvador, David Riedl, Jens Lehmann, Gerhard Rumpold, Alexandra Haid, Verena Schneeberger‐Carta, Bernhard Holzner et al. · 2023 · Transplantation and Cellular Therapy
  29. Patient-physician agreement on function and pain is associated with long-term outcomes in sarcoma: findings from a longitudinal study
    Urška Košir, Deborah van de Wal, Olga Husson, Nadine Zablith, ROBERT E. TURCOTTE · 2023 · Journal of Cancer Survivorship
  30. An analysis of missing items in real-world electronic patient reported outcomes data: implications for clinical care
    Heather A. Rosett, Susan C. Locke, Steven Paul Wolf, Kris W. Herring, Gregory P. Samsa, Jesse D. Troy, Thomas William LeBlanc · 2020 · Supportive Care in Cancer
  31. Big Data Analytics in Health Sector: Need, Opportunities, Challenges, and Future Prospects
    Anam, M. Israrul Haque · 2020 · Emerald Group Publishing Limited eBooks
  32. Comparison of two questionnaires to assess gastrointestinal toxicity in dogs and cats treated with chemotherapy*
    Erin K. Malone, Kenneth M. Rassnick, Dennis B. Bailey, Michael A. Kiselow, Hollis Nancy Erb · 2011 · Veterinary and Comparative Oncology
  33. Overcoming Organizational Challenges of Integrating Patient-Reported Outcomes in Oncology Clinical Trials
    Ari Gnanasakthy, Carla DeMuro · 2015 · Therapeutic Innovation & Regulatory Science
  34. A comparison of nurses’ and physicians’ perception of cancer treatment burden based on reported adverse events
    Shing Mirn Lee, Jieling Miao, Ruby Wu, Joseph M. Unger, Ken Cheung, Dawn L. Hershman · 2019 · Health and Quality of Life Outcomes
  35. Patient Reported Outcomes: Recent Successes and Future Opportunities
    Alexander Melamed, Alexi A. Wright · 2018 · Gynecologic Oncology
  36. Concordance of patient- and clinician-reported outcomes of acute radiation dermatitis in breast cancer
    Milena Gojsevic, Thenugaa Rajeswaran, Liying Zhang, Samantha K. F. Kennedy, Irene Karam, Keyue Ding, Patries M. Herst, Henry C. Y. Wong, Jennifer Y. Y. Kwan, Amir H. Safavi et al. · 2024 · Supportive Care in Cancer
  37. Assessment of Patient-Reported Outcomes in Industry-Sponsored Phase I Oncology Studies: Considerations for Translating Theory Into Practice
    Ari Gnanasakthy, Lindsey Norcross, Kristina A. Fitzgerald · 2023 · Value in Health
  38. PARPi related toxicities: do we need more appropriate instruments to evaluate it?
    Domenica Lorusso, Sandro Pignata · 2018 · Annals of Oncology
  39. Real‑world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration‐resistant prostate cancer
    Takuya Tsujino, Satoshi Tokushige, Kazumasa Komura, Wataru Fukuokaya, Takahiro Adachi, Yosuke Hirasawa, Takeshi Hashimoto, Atsuhiko Yoshizawa, Masanobu Saruta, Takaya Ohno et al. · 2023 · Cancer Medicine
  40. Effect of Accreditation on Patient Safety Culture: Insights from a Brazilian Multicenter Cross-Sectional Study
    Helidea de Oliveira Lima, Leopoldo Muniz da Silva, Rodrigo Gavina da Cruz, Ana Claudia Lopes Fernandes de Araújo, Vanessa de Melo Silva Torres, Deborah Simões, Desiree Stieven Machado, Joaquim Edson Vieira · 2025 · Global Journal on Quality and Safety in Healthcare
  41. GAMBARAN KUALITAS HIDUP PASIEN KANKER LIMFOMA NON HODGKIN YANG DIRAWAT DI RSUP SANGLAH DENPASAR (STUDI PENDAHULUAN)
    Heri Sutrisno, Tjokorda Gde Dharmayuda, Renny A Rena · 2010 · Journal of Internal Medicine
  42. Measuring symptoms as a critical component of drug development and evaluation in hematological diseases
    Loretta A. Williams, Emre Yücel, Jörge E. Cortes, Charles S. Cleeland · 2013 · Clinical Investigation
  43. Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety
    Nicole M. Kuderer, Gary H. Lyman · 2018 · Journal of Clinical Oncology
  44. Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials
    Hannah E. Dzimitrowicz, Andrew J. Armstrong · 2022 · Journal of Clinical Oncology
  45. The landscape of Functional Outcome Measures Used in Patients with Bone Sarcoma of the Lower Extremity or Pelvis: A Systematic Review
    Leonie G Tigelaar, Kiki J. Blom, W. Peter Bekkering, Jos A. M. Bramer, Hendrik W. B. Schreuder, Sherron Furtado, Craig Gerrand, Emanuela Palmerini, Nathalie Gaspar, Sandra J. Strauss et al. · 2024 · Journal of Surgical Oncology
  46. Optimizing Adjuvant Care in Early Breast Cancer: Multidisciplinary Strategies and Innovative Models from Canadian Centers
    Angela W. Chan, Nancy Alice Nixon, Muna Alkhaifi, Alain Bestavros, Christine Blyth, Winson Y. Cheung, Caroline M. Hamm, Thomas Joly‐Mischlich, Mita Manna, Thomas McFarlane et al. · 2025 · Current Oncology
  47. When Does Acceptable Become Unacceptable? Toxicities of Emerging Therapies
    Sydney Barned, Lucie Heinzerling, Lauren A. Dalvin · 2026 · American Society of Clinical Oncology Educational Book
  48. Patient‐reported outcome in colorectal health and disease
    Anjan K. Banerjee · 2012 · Colorectal Disease
  49. Important questions for the malignant hematologist to consider when designing or evaluating a study with patient‐reported outcome measures ( PROMs )
    Amaris Karin Balitsky, Anita D’Souza, Mark N. Levine · 2022 · European Journal Of Haematology
  50. Smartphone-based application and nurses’ interventions for symptoms monitoring in patients treated with oral anticancer agents: A 1-year follow-up in a tertiary cancer center
    Laura Porcher, Valérie Perron, Julie Blanc, Courèche-Guillaume Kaderbhai, Zoé Tharin, Antonin Schmitt, Matthieu Gallet · 2022 · Journal of Oncology Pharmacy Practice
  51. Multicenter, open-label, randomized, controlled study to test the utility of electronic patient-reported outcome monitoring in patients with unresectable advanced cancers or metastatic/recurrent solid tumors
    Naruto Taira, Naomi Kiyota, Yuichiro Kikawa, Eiki Ichihara, Kyoko Kato, Kaoru Kubota, Ryosuke Tateishi, Akinobu Nakata, Keiichiro Nakamura, Yukiya Narita et al. · 2025 · Japanese Journal of Clinical Oncology
  52. Non‑endemic non‑keratinizing nasopharyngeal carcinoma: Long‑term toxicity following chemoradiation
    Julija Jovanovic Ristivojevic, Natasa Jovanovic Korda, Vukac Vujanac, Marina Nikitović, Tatjana Arsenijević · 2025 · Oncology Letters
  53. Information
    William Hersh · 2020 · Health informatics
  54. Development of a conceptual framework to detect perioperative symptom burden following abdominal surgery for cancer
    Emrullah Birgin, Mitho Müller, Christian Franz Josef Woll-Weber, Annika Klompmaker, Patrick Téoule, Christoph Reißfelder, Nuh N. Rahbari · 2023 · European Journal of Surgical Oncology
  55. Patient‐reported physical well‐being predicts good long‐term survival of hematopoietic stem cell transplantation
    Lu Yin, Tao You, Qin Ma, Weijuan Wang, Jiaqian Qi, Pan Yang, Yaya Song, Jia Chen, Jianhong Fu, Yongqin Ge et al. · 2024 · Cancer Medicine
  56. Predictive and Prognostic Significance of Patient‐Reported Outcomes for Survival and Adverse Events in Daratumumab‐Treated Multiple Myeloma
    Ahmad Y. Abuhelwa, Sara A. Almansour, Ethan Basch, Humaid Obaid Al-Shamsi, Ziad Abuhelwa, Yasser Khalil Bustanji, Mohammad Harb Semreen, Zelal Jaber Kharaba, Salma Mohamed Ali, Rawan Mohamed et al. · 2025 · European Journal Of Haematology
  57. Risk factors for serious adverse events due to cytotoxic chemotherapy for advanced non-small cell lung cancer
    Kentaro Suina, Takehito Shukuya, Ryo Koyama, Tetsuhiko Asao, Yuichiro Honma, Motoyasu Kato, Keiko Muraki, Rina Shibayama, Naoko Shimada, Fumiyuki Takahashi et al. · 2016 · Cancer Treatment and Research Communications
  58. Cuarto Consenso Nacional de Cáncer de Ovario
    Dolores Gallardo‐Rincón, Eva Ruvalcaba-Limón, Araceli Silva-García, Carlos Eduardo Aranda-Flores, Odilón Félix Quijano-Castro, Joel Bañuelos-Flores, Gonzalo Montalvo‐Esquivel, Milagros Pérez-Quintanilla, Antonio Bahena-González, Gabriela Alamilla-García et al. · 2018 · Gaceta Mexicana de Oncología
  59. HEALTH-RELATED QUALITY OF LIFE IN ELDERLY
    Emily Ruiz Cavalcante, João Pedro Arantes da Cunha, Paloma Almeida Kowalski, Rachel Carvalho Lemos, José Carlos Souza, José Luís Feltrin Oréfice · 2019 · Simpósio Internacional de Neurociências da Grande Dourados
  60. A feasibility exploratory study of a novel modality of using patient-reported outcomes (PROsEXPLOR) in the real world
    Federica Grosso, Stefania Crivellari, Marinella Bertolotti, Michela Lia, Antonina De Angelis, Antonella Cassinari, Carmela Riccio, Pier Luigi Piovano, Mauro Cappelletti, Antonio Maconi · 2020 · Tumori Journal
  61. Understanding Health-Related Quality of Life in Patients with Mantle Cell Lymphoma
    Priyanka Avinash Pophali, Gita Thanarajasingam · 2020 · Hematology/Oncology Clinics of North America
  62. Survivorship Research: Past, Present, and Future
    Julia Howe Rowland · 2007 · Springer eBooks
  63. Examining the Feasibility of an Application-Based Patient-Reported Outcome Monitoring for Breast Cancer Patients: A Pretest for the PRO B Study
    Anna Maria Hage, Pimrapat Gebert, Friedrich Kühn, Therese Pross, Ulrike Grittner, Maria Margarete Karsten · 2022 · International Journal of Environmental Research and Public Health
  64. Patient-reported outcomes in light of supportive medications in treatment-naïve lung cancer patients
    Johnny M. Hoang, Navneet Upadhyay, Dozie Dike, Jae-Kyu Lee, Michael L. Johnson, Charles S. Cleeland, Tito R. Mendoza, Hua Chen, Meghana V. Trivedi · 2019 · Supportive Care in Cancer
  65. Actualización del tratamiento del cáncer de próstata avanzado y de sus complicaciones
    Ignacio Gil Bazo, Juan Ignacio Martínez‐Salamanca, Fernando J. Bianco · 2005 · Medicina Clínica
  66. Why patient recorded outcomes should be mandatory in and outside clinical trials to guide management of patients with metastatic breast cancer
    Lesley J. Fallowfield · 2007 · Breast Cancer Research
  67. The Use of Patient Reported Outcome Measures and Experiences in Patients With Anaemia Receiving Intravenous Ferric Carboxymaltose: A Cohort Study
    Kerstin Hildegard Wyssusek, Cienwen Town, Rose Norton, Annie Der Avedissian · 2020 · Research Square
  68. Editorial Comment
    Konrad M. Szymanski · 2017 · The Journal of Urology
  69. SYMPTOMS RELEVANT TO SURVEILLANCE FOR OVARIAN CANCER
    Edward J. Pavlik · 2017
  70. Trastuzumab deruxtecan for breast cancer: do patients experience a comprehensive benefit?
    Fernanda Mosele, Massimo Di Maïo · 2023 · Annals of Oncology
  71. App-based assessment of patient-reported outcomes in the Molecular Tumor Board in the Center for Personalized Medicine—(TRACE)
    Lorenz Dörner, Lucia Grosse, Felix Stange, Hanni Hille, Sylvia Christine Kurz, Hannes Becker, Sebastian Volkmer, Melina Hippler, David Rieger, Paula Bombach et al. · 2024 · Neuro-Oncology Practice
  72. Expectations concerning cancer treatment: perspectives of medical oncologists and patients on advanced, unresectable lung carcinoma
    Patricia Cruz‐Castellanos, Paula Jiménez‐Fonseca, Rocío Galán-Moral, Nuria Piera, Marina Gustems, Caterina Calderón · 2024 · Frontiers in Psychology
  73. A patient-centered approach to developing and validating a natural language processing model for extracting patient-reported symptoms
    Satoshi Watabe, Yuki Yanagisawa, Kyoko Sayama, Sakura Yokoyama, Mitsuhiro Someya, Ryoo Taniguchi, Shuntaro Yada, Eiji Aramaki, Hayato Kizaki, Masami Tsuchiya et al. · 2025 · Scientific Reports
  74. Tutorial on Analyzing Patient‐Reported Outcome Measures in Clinical Development
    Krina Mehta, Jim Henry Hughes, Jiawei Zhou, Benyam Muluneh, Ari Gnanasakthy · 2026 · Clinical and Translational Science
  75. Application of Data Analytics in Healthcare Management: A Comprehensive Review
    Anjali Singh, Sukeshini B. Lote · 2024 · DMIHER International Conference on Artificial Intelligence in Healthcare, Education and Industry (IDICAIHEI)
  76. Electronic patient-reported adverse event monitoring in academic early-phase clinical trials: A feasibility study
    Leanne Shearsmith, Sarah J. Danson, Sarah Gelcich, Andrea Gibson, Kathryn Gordon, Fiona Jane Collinson, Julie Croft, Emma Griffiths, Zoe Rogers, Robert Carter et al. · 2025 · Clinical Trials
  77. PROMIS in oncology: A review of current applications and practical considerations for clinical integration
    Connor D. Eyre, Kristen L. Thompson · 2026 · Advances in Patient-Reported Outcomes
  78. Maternal/infant Characteristics And Birth Location Impact On Breastfeeding Initiation And Duration
    Laura Börk, Marjorie J. Bott · 2015 · KU ScholarWorks (University of Kansas)
  79. Prevalence of cognitive impairments following chemotherapy and its relationship to depression in Japanese breast cancer survivors: an exploratory study
    Hitoshi Tanimukai · 2018 · International Journal of Complementary & Alternative Medicine
  80. Quality of Life
    Elizabeth J. Siembida, John M. Salsman · 2022 · Springer eBooks
  81. Protecting the Heart in Cancer Patients: The Role of Cardio-Oncology
    Ronald J. Krone · 2017 · EMJ Cardiology
  82. Patient-reported distress at a cancer center during the COVID-19 pandemic
    Manan P. Shah, Sarah W. Rosenthal, Mohana Roy, Ali Raza Khaki, Tina Hernandez‐Boussard, Kavitha J. Ramchandran · 2023 · Scientific Reports
  83. Parents' perception of treatment‐related toxicity in children treated according to the NOPHO ALL2008 protocol for acute lymphoblastic leukemia
    Nina Mogensen, Ulrika C. Kreicbergs, Birgitte Klug Albertsen, Päivi M. Lähteenmäki, Mats Marshall Heyman, Arja H. Harila‐Saari · 2024 · HemaSphere
  84. A Pilot Study on the Collection of Adverse Event Data from the Patient Using an Electronic Platform in a Cancer Clinical Trial Unit
    Minna Grahvendy, Bena Brown, Laurelie R. Wishart · 2024 · Drugs - Real World Outcomes
  85. Engaging survivor and oncologist stakeholders to develop a patient-reported outcome assessment to use as a component of survivorship care
    Heather B. Neuman, Kristine L. Kwekkeboom, Amye Juliet Tevaarwerk, Kat Phelps, Jennifer L. Tucholka, Courtney Maxcy, Catherine R. Breuer, Jessica R. Schumacher · 2024 · Supportive Care in Cancer
  86. Putting Patients First: Pragmatic Trials in Gynecologic Oncology
    Laura Hopkins, Mark J. Clemons, Karen Bemister, Chris M. Booth, Shannon Kadar, Paul Karanicolas, JM Mulligan, Marie-France Savard, Ian F. Tannock, Alicia A. Tone et al. · 2025 · Current Oncology
  87. Assessing treatment tolerability for rheumatoid arthritis. Validation and practical applications of the ‘TOL-AR-18 questionnaire’
    Hèctor Corominas, Luís Espadaler, Antoni Gómez, Inmaculada Ros, Ana Urruticoechea, Mònica Sarmiento, Raimón Sanmartí · 2018 · Reumatología Clínica
  88. Pediatric Palliative Care
    Stefan J. Friedrichsdorf · 2019 · MDPI eBooks
  89. Mucositis
    Jennifer Novak, Arya Amini · 2021 · Springer eBooks
  90. Ovarian Cancer Screening
    Edward J. Pavlik · 2018 · MDPI eBooks
  91. Patient-Reported Tolerability in Oncology Drug Development
    Jessica K. Roydhouse, Ethan Basch, Monique C. Breslin, Melanie Calvert, David F Cella, Amylou Constance Dueck, Bryce B. Reeve, Mary Lou Smith, Gita Thanarajasingam, Lynne I. Wagner et al. · 2024 · ICSA book series in statistics
  92. The difficulties industry is facing with investigators
    George R. P. Blackledge · 2005 · European Journal of Cancer
  93. Graded NTCP dynamics: leveraging patient-reported outcomes to explore response and cross-toxicity trade-offs in head and neck cancer
    Daniel J. Glazar, Ryan Werthmann, Niema B. Razavian, Renee Brady‐Nicholls · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Developing an evidence based approach to follow up in breast cancer
    David A. Montgomery · 2008 · Enlighten: Theses (The University of Glasgow)
  95. Evidence-Based Head and Neck Oncology: Principles and Pitfalls
    Søren Møller Bentzen · 2011 · Springer eBooks
  96. SIOG (International Society of Geriatric Oncology) and anthracycline use in the elderly
    Matti Aapro · 2011 · European Journal of Cancer Supplements
  97. Can a self-reported questionnaire replace interview assessments for detection of late radiation sequelae in prostate cancer patients treated by radical irradiation?
    Christian Magnus Borthen Langberg · 2009 · NORA - Norwegian Open Research Archives
  98. Quality of life of cancer patients on the wave of immunotherapy
    Fernanda Bohns Pruski Ramos, André Poisl Fay · 2016 · Expert Review of Quality of Life in Cancer Care
  99. The Effect of Exemestane on Menopause-Specific Health-Related Quality of Life and a Comparison With Clinician-Reported Toxicities: an Analysis of the NCIC CTG MAP.2 Chemoprevention Trial
    Natalie Causarano · 2012 · QSpace (Queen's University Library)
  100. A study on parental perception towards children's palliative with special reference to solace thissur.
    Thulasi Sathyan, Kumar Sai Sailesh · 2018